V

Vericel Corp
D

VCEL

59.070
USD
2.75
(4.88%)
مغلق
حجم التداول
9,061
الربح لكل سهم
0
العائد الربحي
-
P/E
738
حجم السوق
2,915,601,161
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABMD
    0
    (0%)
    0 USD
    A
    ALGN
    5.280
    (2.41%)
    224.340 USD
    B
    BAX
    0.020
    (0.06%)
    30.970 USD
    BSX
    BSX
    0.463
    (0.47%)
    98.643 USD
    EW
    EW
    -0.080
    (-0.11%)
    69.790 USD
    ISRG
    ISRG
    8.60
    (1.47%)
    592.67 USD
    M
    MTD
    -1.17
    (-0.09%)
    1,296.00 USD
    RMD
    RMD
    2.610
    (1.10%)
    239.700 USD
    STE
    STE
    -0.560
    (-0.27%)
    209.590 USD
    TMO
    TMO
    -1.98
    (-0.35%)
    559.67 USD
    المزيد
الأخبار
المقالات

العنوان: Vericel Corp

القطاع: Healthcare
الصناعة: Biotechnology
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in various therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.